Related Experiment Video
Updated: May 10, 2026
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
[Long-term mechanical circulatory support: where do we stand in 2013?]
1Centre Cardiovasculaire, Service de cardiologie, HUG, Genève. stephane.reverdin@hcuge.ch
Revue Medicale Suisse
|June 25, 2013
Summary
Mechanical circulatory support (MCS) is increasingly used, with a trend towards earlier implantation. Optimal patient management requires a multidisciplinary approach from pre-implantation through long-term support.
Area of Science:
- Cardiology and Mechanical Circulatory Support
Context:
- Advancements in technology are expanding experience with long-term mechanical circulatory support (MCS).
- Patient selection for MCS relies on specific indications, concepts, and classifications.
- Improving outcomes and evidence support earlier implantation of MCS devices.
Purpose:
- To outline the evolving landscape of mechanical circulatory support.
- To emphasize the importance of pre-implant follow-up for optimal timing.
- To highlight the unique hemodynamic considerations in patients with continuous-flow ventricular assist devices.
Summary:
- Experience with long-term mechanical circulatory support (MCS) is growing due to technological advancements.
- A trend towards earlier implantation is observed, necessitating adequate pre-implant evaluation to identify the optimal window.
- Managing patients on chronic support, particularly those with continuous-flow ventricular assist devices, requires attention to hydration status and a multidisciplinary approach.
Impact:
- Enhanced understanding of patient selection and timing for MCS implantation.
- Recognition of the unique hemodynamic challenges in patients with continuous-flow ventricular assist devices.
- Advocacy for a multidisciplinary management strategy, mirroring organ transplantation protocols, for improved long-term outcomes.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...